September 14, 2022, Vientiane, Laos--BioSpring ("BioSpring Group.LTD" "BioSpring Group") launches New Product Packaging for SaiLin's Global Market Customers.
This product packaging upgrade is to fulfill the previous promise of BioSpring's acquisition of SaiLin, and will continue to provide follow-up support and services to Sailin's global customers. The batch will use Biospring's anti-counterfeiting verification system.
| No. 1 | Saibriga |
|---|---|
| Brand name | Saibriga |
| Compositon | Brigatinib |
| Strength | 90mg |
| Form | Tablet |
| Quantity Unit | 90mg*30T/bottle |
| Date of manufacture | September.2022 |
| Product Verification | www.biospring.ltd |
| Licensor | Sailin biopharmaceutical (Laos) co., LTD |
| Manufacturer | BioSpring.Ltd.,Laos PDR |
| No. 2 | Saibru |
|---|---|
| Brand name | Saibru |
| Compositon | Ibrutinib |
| Strength | 140mg |
| Form | Capsule |
| Quantity Unit | 140mg*90C/bottle |
| Date of manufacture | September.2022 |
| Product Verification | www.biospring.ltd |
| Licensor | Sailin biopharmaceutical (Laos) co., LTD |
| Manufacturer | BioSpring.Ltd.,Laos PDR |
| No. 3 | Saicabo |
|---|---|
| Brand name | Saicabo |
| Compositon | Cabozantinib |
| Strength | 20mg |
| Form | Capsule |
| Quantity Unit | 20mg*90C/bottle |
| Date of manufacture | September.2022 |
| Product Verification | www.biospring.ltd |
| Licensor | Sailin biopharmaceutical (Laos) co., LTD |
| Manufacturer | BioSpring.Ltd.,Laos PDR |
| No. 4 | Saicapma |
|---|---|
| Brand name | Saicapma |
| Compositon | Capmatinib |
| Strength | 200mg |
| Form | Tablet |
| Quantity Unit | 200mg*56T/bottle |
| Date of manufacture | September.2022 |
| Product Verification | www.biospring.ltd |
| Licensor | Sailin biopharmaceutical (Laos) co., LTD |
| Manufacturer | BioSpring.Ltd.,Laos PDR |
| No. 5 | Saicrizo |
|---|---|
| Brand name | Saicrizo |
| Compositon | Crizotinib |
| Strength | 250mg |
| Form | Capsule |
| Quantity Unit | 250mg*60C/bottle |
| Date of manufacture | September.2022 |
| Product Verification | www.biospring.ltd |
| Licensor | Sailin biopharmaceutical (Laos) co., LTD |
| Manufacturer | BioSpring.Ltd.,Laos PDR |
| No. 6 | Sailorla |
|---|---|
| Brand name | Sailorla |
| Compositon | Lorlatinib |
| Strength | 25mg |
| Form | Tablet |
| Quantity Unit | 25mg*30T/bottle |
| Date of manufacture | September.2022 |
| Product Verification | www.biospring.ltd |
| Licensor | Sailin biopharmaceutical (Laos) co., LTD |
| Manufacturer | BioSpring.Ltd.,Laos PDR |
| No. 7 | Saiosimer |
|---|---|
| Brand name | Saiosimer |
| Compositon | Osimertinib |
| Strength | 80mg |
| Form | Tablet |
| Quantity Unit | 80mg*30T/bottle |
| Date of manufacture | September.2022 |
| Product Verification | www.biospring.ltd |
| Licensor | Sailin biopharmaceutical (Laos) co., LTD |
| Manufacturer | BioSpring.Ltd.,Laos PDR |
About BioSpring.Ltd
Founded in 2022 at the Vientiane Saiseta Comprehensive Development Zone in Laos, BioSpring is the country's fastest growing generic drug manufacturing company and the country's first pharmaceutical company targeting the international market, serving Asia, Africa, Europe and Latin America Americas and many other countries and regions.
About Sailin Biopharma
Sailin biopharmaceutical (Laos) co., LTD., and the construction in 2019, is currently the largest and the most technologically advanced Laos anticancer and antiviral drugs production enterprise joint pharmaceutical group co., LTD., a subsidiary of the country's fastest growing large pharmaceutical companies.
Sailin pharmaceutical is a pharmaceutical enterprise management practices, in vientiane Rosetta park covers an area of 60 mu, raw material production and preparation production is equal to one, the company has more than 152 employees.Visit: Lao pharmaceutical company BioSpring announces acquisition agreement with cancer drug company Sailin Biopharma - BioSpring.Ltd
About Pharmaceutical Third Party Manufacturing
Pharma Third party manufacturing/contract manufacturing provide easy solution for manufacturing of own brands.
Third party or contract manufacturing is referred to out sourcing of products or to get manufactured one’s brand names from others manufacturing unit out. In current time it is very popular concept among marketing companies. Even companies having their own manufacturing units are gotten manufactured their products from outside. Multinational companies are also gotten manufactured their products at loan license or third party basis.
Third Party/Contract Party Manufacturers Agency
RxLibra pharmaceutical Sole Co.,Ltd
Forward-Looking Statements
To the extent applicable laws and regulations, expressions such as "plan," "target," "expect," "forecast," and similar expressions appearing in this press release are forward-looking statements. The forward-looking statements set forth herein involve a number of risks and uncertainties that may differ materially from actual results. Important factors leading to such differences include, but are not limited to, changes in regulations and/or economic conditions, uncertainty in clinical research results, exposure to various market risks, and other factors beyond the control of the company.
January 10, 2023, Vientiane, Laos--BioSpring ("BioSpring Group.LTD" "BioSpring Group") is launching Generic (Molnupiravir 200mg) capsules & Generic 150mg Nirmatrelvir/ 100mg Ritonavir tablets KIT for the treatment of Covid-19 virus infection. Molnupiravir is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat COVID-19 in those infected by SARS-CoV-2. It is taken by mouth.The Generic…
September 08, 2022, Vientiane, Laos--BioSpring ("BioSpring Group.LTD" "BioSpring Group") is launching Tadazen (tadalafil) tablet for customers, which will be available in a single strength of 20mg, and each box of tadazen includes 8 tablets.It is a tablet taken by mouth. Onset is typically within half an hour and the duration is up to 36 hours. This product is manufactured and produced by…
September 07, 2022, Vientiane, Laos--BioSpring ("BioSpring Group.LTD" "BioSpring Group") announces coommerical packaging solutions for formulation manufacturing. Completing the prefabrication process for this commercial package ahead of time will help shorten the overall manufacturing cycle. Samuel, founder and CEO of BioSpring, said: “BioSpring can help customers overcome the challenges of formulating, processing and scaling up manufacturing of generic drugs.” Days it takes…
